These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8339385)
1. Effect of toremifene on the growth, hormone receptors and insulin-like growth factor-1 of hormone-dependent MCF-7 tumors in athymic mice. Iino Y; Takai Y; Ando T; Sugamata N; Maemura M; Takeo T; Ohwada S; Morishita Y Cancer Chemother Pharmacol; 1993; 32(5):353-8. PubMed ID: 8339385 [TBL] [Abstract][Full Text] [Related]
2. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse. Robinson SP; Jordan VC Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347 [TBL] [Abstract][Full Text] [Related]
3. A new triphenylethylene derivative, TAT-59; hormone receptors; insulin-like growth factor 1; and growth suppression of hormone-dependent MCF-7 tumors in athymic mice. Iino Y; Takai Y; Ando T; Ohwada S; Yokoe T; Sugamata N; Takei H; Horiguchi J; Iijima K; Morishita Y Cancer Chemother Pharmacol; 1994; 34(5):372-6. PubMed ID: 8070003 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of hormone-dependent and independent breast cancer cell growth in vivo and in vitro with the antiestrogen toremifene and recombinant human interferon-alpha 2. Robinson SP; Goldstein D; Witt PL; Borden EC; Jordan VC Breast Cancer Res Treat; 1990 Feb; 15(2):95-101. PubMed ID: 2138919 [TBL] [Abstract][Full Text] [Related]
5. Preclinical studies with toremifene as an antitumor agent. Robinson SP; Parker CJ; Jordan VC Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S9-17. PubMed ID: 2149286 [TBL] [Abstract][Full Text] [Related]
6. Toremifene in postmenopausal breast cancer. Efficacy, safety and cost. Mäenpää JU; Ala-Fossi SL Drugs Aging; 1997 Oct; 11(4):261-70. PubMed ID: 9342556 [TBL] [Abstract][Full Text] [Related]
7. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929 [TBL] [Abstract][Full Text] [Related]
8. Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells. Kuramoto M; Yamashita J; Ogawa M Cancer; 1995 Mar; 75(6):1263-72. PubMed ID: 7882277 [TBL] [Abstract][Full Text] [Related]
9. Reversible control of oestradiol-stimulated growth of MCF-7 tumours by tamoxifen in the athymic mouse. Iino Y; Wolf DM; Langan-Fahey SM; Johnson DA; Ricchio M; Thompson ME; Jordan VC Br J Cancer; 1991 Dec; 64(6):1019-24. PubMed ID: 1764361 [TBL] [Abstract][Full Text] [Related]
11. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976 [TBL] [Abstract][Full Text] [Related]
12. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162 [TBL] [Abstract][Full Text] [Related]
13. Regulation of estrogen receptor and epidermal growth factor receptor by tamoxifen under high and low estrogen environments in MCF-7 cells grown in athymic mice. Koibuchi Y; Iino Y; Uchida T; Andoh T; Horii Y; Nagasawa M; Horiguchi J; Maemura M; Takei H; Yokoe T; Morishita Y Oncol Rep; 2000; 7(1):135-40. PubMed ID: 10601607 [TBL] [Abstract][Full Text] [Related]
14. Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha. Chisamore MJ; Ahmed Y; Bentrem DJ; Jordan VC; Tonetti DA Clin Cancer Res; 2001 Oct; 7(10):3156-65. PubMed ID: 11595710 [TBL] [Abstract][Full Text] [Related]
15. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice. Schafer JM; Lee ES; O'Regan RM; Yao K; Jordan VC Clin Cancer Res; 2000 Nov; 6(11):4373-80. PubMed ID: 11106256 [TBL] [Abstract][Full Text] [Related]
16. Influence of hormones on tumor growth, cell kinetics, estrogen receptor and insulin-like growth factor-I-related protein of human breast cancer (MCF-7) cells transplanted in nude mice. Noguchi M; Thomas M; Koyasaki N; Ohta N; Taniya T; Kitagawa H; Miyazaki I; Mizukami Y Mol Cell Endocrinol; 1993 Mar; 92(1):69-76. PubMed ID: 8472869 [TBL] [Abstract][Full Text] [Related]
17. Tissue distribution of transdermal toremifene. Soe L; Wurz GT; Mäenpää JU; Hubbard GB; Cadman TB; Wiebe VJ; Theon AP; DeGregorio MW Cancer Chemother Pharmacol; 1997; 39(6):513-20. PubMed ID: 9118463 [TBL] [Abstract][Full Text] [Related]
18. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Chen J; Power KA; Mann J; Cheng A; Thompson LU Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953 [TBL] [Abstract][Full Text] [Related]
19. Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer. Jordan VC; Gottardis MM; Robinson SP; Friedl A J Steroid Biochem; 1989; 34(1-6):169-76. PubMed ID: 2626014 [TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]